Wed, Aug 27, 2014, 9:52 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • stockgawd stockgawd Mar 21, 2013 9:25 PM Flag

    A Sign of the Times - AstraZeneca's Drung Patents Expiring

    (Reuters) - AstraZeneca's new chief executive announced another 2,300 job cuts in sales and administration on Thursday as he set out his stall for turning round the struggling drugmaker and returning it to growth.
    The latest cutbacks mean the group will shed around a tenth of its workforce, or 5,050 jobs, by 2016 as expiring drug patents shrink sales and it faces generic competition on several top-selling medicines.

    Pascal Soriot said he had no quick fix for the company and ruled out the idea of diversifying away from prescription drugs, as several rivals have done. He plans instead to invest in scientific research to replenish a sparse new drug pipeline.

    It promises to be a long haul. Still, AstraZeneca believes it can double the number of drugs in late-stage development by 2016 and by 2018 it expects revenue to "significantly exceed" the current market consensus of $21.5 billion.

    Research efforts will in future focus on three main disease areas and AstraZeneca will strike more external deals - following a $240 million tie-up with Moderna Therapeutics - to bring in new products, particularly in specialty medicine.

    A key figure in getting deals done will be new hire Marc Dunoyer, who is joining from rival drugmaker GlaxoSmithKline as head of global portfolio and product strategy.

    Investors may be reluctant to give Soriot too much credit until they see concrete signs of new drugs nearing the market.

4.12-0.03(-0.72%)Aug 27 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Williams-Sonoma Inc.
NYSEWed, Aug 27, 2014 4:01 PM EDT
TubeMogul, Inc.
NasdaqGSWed, Aug 27, 2014 4:00 PM EDT
Burger King Worldwide, Inc.
NYSEWed, Aug 27, 2014 4:00 PM EDT